Toronto Dominion Bank’s DiaMedica Therapeutics DMAC Stock Holding History

Toronto Dominion Bank’s Portfolio DMAC Stock Details DMAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$162	Hold	24	–	–	﹤0.01%	2061
2025 Q4	$191	Hold	24	–	–	﹤0.01%	2001
2025 Q3	$165	Buy	+24	New	+$130	﹤0.01%	1871
2024 Q3	–	Sell	-24	Closed	-$71	–	1228
2024 Q2	$71	Hold	24	–	–	﹤0.01%	1380
2024 Q1	$66	Hold	24	–	–	﹤0.01%	1361
2023 Q4	$68	Hold	24	–	–	﹤0.01%	1493
2023 Q3	$62	Hold	24	–	–	﹤0.01%	1724
2023 Q2	$0	Hold	24	–	–	﹤0.01%	1551
2023 Q1	$0	Buy	+24	New	+$38	﹤0.01%	1495
2022 Q3	–	Sell	-24	Closed	–	–	1579
2022 Q2	$0	Hold	24	–	–	﹤0.01%	1451
2022 Q1	$0	Hold	24	–	–	﹤0.01%	1547
2021 Q4	$0	Hold	24	–	–	﹤0.01%	1609
2021 Q3	$0	Hold	24	–	–	﹤0.01%	1395
2021 Q2	$0	Hold	24	–	–	﹤0.01%	1398
2021 Q1	$0	Hold	24	–	–	﹤0.01%	1478
2020 Q4	$0	Hold	24	–	–	﹤0.01%	1365
2020 Q3	$0	Hold	24	–	–	﹤0.01%	1254
2020 Q2	$0	Hold	24	–	–	﹤0.01%	1267
2020 Q1	$0	Hold	24	–	–	﹤0.01%	1283
2019 Q4	$0	Hold	24	–	–	﹤0.01%	1393
2019 Q3	$0	Sell	24 -24	-50%	-$78	﹤0.01%	1496
2019 Q2	$0	Buy	+48	New	+$166	﹤0.01%	1516
2019 Q1	–	Sell	-45	Closed	–	–	1587
2018 Q4	$0	Buy	+45	New	+$141	﹤0.01%	1526

Other funds holding DMAC

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Toronto Dominion Bank's DMAC Position: Q1 2026 in Review

Toronto Dominion Bank held its DiaMedica Therapeutics (DMAC) position steady in Q1 2026 at 24 shares worth $162. The position accounts for ﹤0.01% of the portfolio, ranked #2061.

Toronto Dominion Bank first reported a position in DMAC in Q4 2018 and has held it in 23 quarters since. The position peaked at $191 in Q4 2025. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

Toronto Dominion Bank held 24 shares of DiaMedica Therapeutics worth $162 as of Q1 2026.
Toronto Dominion Bank left its DiaMedica Therapeutics share count unchanged in Q1 2026.
DiaMedica Therapeutics made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #2061 holding.
Toronto Dominion Bank first reported a position in DiaMedica Therapeutics in Q4 2018 and has held it in 23 quarters since.
Toronto Dominion Bank's DiaMedica Therapeutics position peaked at $191 in Q4 2025.
98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.